MAZZONE, ELIO
 Distribuzione geografica
Continente #
EU - Europa 2.295
AS - Asia 1.396
NA - Nord America 1.253
SA - Sud America 305
AF - Africa 45
OC - Oceania 4
Totale 5.298
Nazione #
RU - Federazione Russa 1.227
US - Stati Uniti d'America 1.183
CN - Cina 459
SG - Singapore 408
IT - Italia 324
BR - Brasile 250
SE - Svezia 200
HK - Hong Kong 197
DE - Germania 186
VN - Vietnam 149
FR - Francia 74
GB - Regno Unito 61
FI - Finlandia 57
IN - India 51
NL - Olanda 50
CA - Canada 42
ES - Italia 27
MX - Messico 24
JP - Giappone 22
PL - Polonia 21
AR - Argentina 18
IQ - Iraq 16
ZA - Sudafrica 14
CH - Svizzera 13
EG - Egitto 13
EC - Ecuador 12
AT - Austria 10
BD - Bangladesh 10
ID - Indonesia 10
LT - Lituania 10
TR - Turchia 10
BE - Belgio 8
MA - Marocco 7
PH - Filippine 7
IR - Iran 6
MY - Malesia 6
PK - Pakistan 6
PT - Portogallo 6
SA - Arabia Saudita 6
VE - Venezuela 6
CO - Colombia 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
KR - Corea 4
PE - Perù 4
TW - Taiwan 4
UA - Ucraina 4
AU - Australia 3
IL - Israele 3
KH - Cambogia 3
NG - Nigeria 3
SN - Senegal 3
UY - Uruguay 3
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
LB - Libano 2
NP - Nepal 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 5.298
Città #
Singapore 248
Moscow 219
Ashburn 200
Hong Kong 178
Dallas 158
San Jose 121
New York 100
Shanghai 99
Milan 95
Beijing 80
Hefei 56
Ho Chi Minh City 55
Los Angeles 53
Lauterbourg 50
Lawrence 42
Princeton 42
Munich 37
Hanoi 34
Helsinki 25
Boardman 24
Orem 24
Montreal 22
Tokyo 22
Turku 22
Chennai 19
São Paulo 19
Denver 17
Frankfurt am Main 16
Amsterdam 15
Santa Clara 15
Stockholm 15
Warsaw 15
Da Nang 13
Rome 13
Brooklyn 12
London 12
Manchester 11
Nuremberg 11
Guangzhou 10
Atlanta 9
Chicago 9
Council Bluffs 9
Johannesburg 9
Palermo 9
Hung Hom 8
Mumbai 8
Rio de Janeiro 8
Turin 8
Boston 7
Brescia 7
Cairo 7
Houston 7
Irvine 7
Mexico City 7
Phoenix 7
Pune 7
San Francisco 7
Baghdad 6
Barnet 6
Belo Horizonte 6
Guayaquil 6
Lappeenranta 6
Lausanne 6
Naples 6
Querétaro 6
Toronto 6
Vienna 6
Bennekom 5
Brasília 5
Brussels 5
Buffalo 5
Dalian 5
Istanbul 5
Lisbon 5
Nanyang 5
New Delhi 5
Seattle 5
Vancouver 5
Alexandria 4
Ankara 4
Biên Hòa 4
Bologna 4
Borås 4
Campinas 4
Columbus 4
Curitiba 4
Jiaxing 4
Nova Iguaçu 4
Petrópolis 4
Poplar 4
Porto Alegre 4
Salamanca 4
The Dalles 4
Aci Sant'antonio 3
Bexley 3
Bodmin 3
Caxias do Sul 3
Cesano Boscone 3
Charleston 3
Charlotte 3
Totale 2.555
Nome #
INTEGRATING PSMA EXPRESSION PATTERNS, MORPHOLOGICAL AND CLINICAL FEATURES TO OPTIMIZE DETECTION OF NODAL METASTASES IN PATIENTS TREATED WITH PSMA RADIO-GUIDED ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION 360
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 171
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 155
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 155
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 139
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 139
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 134
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 120
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 119
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 116
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 112
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 111
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 110
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 108
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 107
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 107
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 106
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 105
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 100
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 99
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 97
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 96
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 94
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 94
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 93
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 92
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 91
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups 89
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 88
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis 88
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series 84
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy 82
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality 76
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes 75
Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 73
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study 73
Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study 72
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates 71
Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis 70
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 69
Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based study 68
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients 66
The effect of race on survival after local therapy in metastatic prostate cancer patients 65
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 64
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma 61
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 60
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis 60
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma 59
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 58
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample 56
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 55
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract 55
Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis 54
Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies 50
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 50
Primary lymphomas of the genitourinary tract: A population-based study 49
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes 45
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma 44
Trends and social barriers for inpatient palliative care in patients with metastatic bladder cancer receiving critical care therapies 41
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score 7
null 1
Totale 5.408
Categoria #
all - tutte 25.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202243 0 6 2 18 0 3 1 1 0 0 0 12
2022/2023322 109 73 29 13 5 33 7 27 13 0 6 7
2023/2024396 2 18 38 22 28 88 6 38 6 38 45 67
2024/20251.172 104 52 40 100 64 117 183 116 108 82 89 117
2025/20263.444 240 234 186 441 312 108 278 361 1.084 200 0 0
Totale 5.408